ASTRAZENECA PLC
AZNLatest QuantConomy context for AZN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
ASTRAZENECA PLC
AstraZeneca PLC (AZN) is a British-Swedish multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in Cambridge, England. Formed in 1999 through the merger of Astra AB of Sweden and Zeneca PLC of the United Kingdom, the company is one of the world's largest pharmaceutical companies. AstraZeneca focuses on developing and commercializing prescription medicines in several therapeutic areas, including oncology, cardiovascular, respiratory, gastrointestinal, and rare diseases. The company is listed on the London Stock Exchange, Nasdaq Stockholm, and Nasdaq under the symbol AZN, with its American Depositary Receipts (ADRs) traded on Nasdaq with a 2:1 ratio to its ordinary shares. AstraZeneca is known for its significant research and development efforts, including its involvement in the development of the Oxford–AstraZeneca COVID-19 vaccine and various strategic acquisitions to expand its portfolio of treatments.
- Symbol
- AZN
- Name
- ASTRAZENECA PLC
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq lse
Recent signals for AZN
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| volume spike | neutral | 37 | Jul 10, 05:20 PM | AZN volume spike: 253% of expected volume for Friday 17:00 UTC, price flat 0.01% (strength 37) |
| volume spike | neutral | 39 | Jul 10, 04:07 PM | AZN volume spike: 328% of expected volume for Friday 16:00 UTC, price flat 0.06% (strength 39) |
| major spike | bearish | 100 | Jul 10, 03:35 PM | AZN major volume spike: 4315% of expected volume for Friday 15:00 UTC, price down 3.30% (strength 100) |
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| AZN | NASDAQ | alphavantage | Astrazeneca plc |
| AZN | NASDAQ | alpaca | AstraZeneca PLC American Depositary Shares |
| AZN | NASDAQ | fmp | AstraZeneca PLC |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Sharma Mani | See Remarks | grant | 2 | $190.43 | $381 | 4 on EDGAR |
| May 20, 2026 | Sharma Mani | See Remarks | sale | 11,893 | $185.78 | $2,209,482 | 4 on EDGAR |
| Apr 7, 2026 | Sharma Mani | See Remarks | grant | 1 | $196.03 | $196 | 4 on EDGAR |
| — | Sharma Mani | See Remarks | — | — | — | — | 3 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query AZN context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access